Europe
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
The company said rapastinel will not likely hit primary and secondary endpoints in three acute studies based on data from an interim analysis.
Epigenomics AG today has decided to terminate its collaboration with its Chinese partner BioChain for the licensing of the Septin9 marker and the exclusive distribution rights in China for Epi proColon
SynGEM a needle-free nasal spray vaccine against respiratory syncytial virus
The European Patent Office has granted a patent for Sangui’s proposed technology/treatment (SBT 102) for septic shock patients, effective March, 6, 2019*.
Medtronic plc today announced that, pursuant to the previously-announced cash tender offers
Unique solution offers sponsors a streamlined approach to the global supply chain
Biotech and pharma companies from across the globe share data and news in a weekly roundup.
Data show how gp-ASIT+™, administered in a pre-seasonal 3-week treatment, is able to rapidly modulate pro-allergic cellular response and induce production of blocking antibodies. This effect led to a significant reduction in the combined clinical symptom and medication score during the following pollen season.
First company to receive authorization to market this pure synthetic micronutrient in the European Union
PRESS RELEASES